Thijs Schaap

Impact investing in Health @ Noaber & Nextgen Ventures

📍 Netherlands🔄 Updated September 2026💼 9 investments📅 6 years investing🗓 Last invested Dec 2025
VC🌍 NetherlandsInvested this year
9
Total investments
3
Early stage
4
Mid stage
1
Late stage
6y
Years active

Portfolio

8 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Observer
Dec 2025
Meela is a research-based matching platform connects people with their best-fit therapists, making the journey to better mental wellbeing feel safe and effective. With the largest network of licensed psychologists and psychotherapists in Sweden and the London area, Meela has helped over 90,000 people find their perfect therapeutic match, and 9 out of 10 say they got a perfect match. The relationship between client and therapist is one of the strongest indicators of whether therapy will be successful. That’s why Meela offers a matching guarantee: if after the first session things dont feel right, Meela will help find a new therapist and cover the cost of that first session with them, to make it a little easier to start over. Meela welcomes everyone, wherever theyre at in life and whatever journey theyre facing. Sometimes we all need help – and thats a good thing.
Board Observer
Jan 2025
Powering access to eyecare for everyone by connecting opticians and ophthalmologists through our eye health software platform MIRA - leveraging Telemedicine, AI and a network of over 400 ophthalmologists in Europe
Early Investor
Feb 2024
Vaalia is reimagining medication management for cancer and specialty care. We combine human coaching with causal AI to help patients manage their medications, stay on therapy, and achieve better outcomes. Our platform learns from real patient interactions and integrates with clinics to deliver personalized, evidence-driven support where it matters most.
Board Observer
May 2023
Alba Health is on a mission to improve the health of next generations. Join our movement to fight the chronic disease epidemic from childhood.
Board Observer
Sep 2022
The world spends trillions treating type 2 diabetes and prediabetes, throwing pills at the problem and focusing on disease management—all while ignoring the underlying causes. We built Habitual to change this. We harness innovations in digital therapeutics combined with rigorously validated nutritional strategies to deliver scalable, personalised, and effective treatment for type 2 diabetes and prediabetes.
Board Member
Dec 2021
Newsenselab GmbH has developed M-sense Migraine. The application supports migraine sufferers in reducing their headaches and dealing with their condition in a self-determined manner. The innovative digital treatment program was developed together with leading headache specialists.
Early Investor
Aug 2021
Buurtdokters staat voor toekomstbestendige, patiënt- en zorgverlenervriendelijke huisartsenzorg.
Board Observer
May 2021
Sweetch is the first behavioral science company to leverage AI & EI (emotional intelligence) through its digital therapeutics solutions. Its hyper-personalized engagement platform enables health ecosystem players to build continuous relationships and engage with every individual patient, at scale.
Experience · 12 entries
All (12)
Investments (9)
Board (6)
2025
Board Observer
Dec 2025
Meela is a research-based matching platform connects people with their best-fit therapists, making the journey to better mental wellbeing feel safe and effective. With the largest network of licensed psychologists and psychotherapists in Sweden and the London area, Meela has helped over 90,000 people find their perfect therapeutic match, and 9 out of 10 say they got a perfect match. The relationship between client and therapist is one of the strongest indicators of whether therapy will be successful. That’s why Meela offers a matching guarantee: if after the first session things dont feel right, Meela will help find a new therapist and cover the cost of that first session with them, to make it a little easier to start over. Meela welcomes everyone, wherever theyre at in life and whatever journey theyre facing. Sometimes we all need help – and thats a good thing.
Board Observer
Jan 2025
Powering access to eyecare for everyone by connecting opticians and ophthalmologists through our eye health software platform MIRA - leveraging Telemedicine, AI and a network of over 400 ophthalmologists in Europe
Investment Manager
Jan 2025
NextGen Ventures invests in innovative companies that drive change in healthcare. info@nextgenventures.nl
2024
Early Investor
Feb 2024
Vaalia is reimagining medication management for cancer and specialty care. We combine human coaching with causal AI to help patients manage their medications, stay on therapy, and achieve better outcomes. Our platform learns from real patient interactions and integrates with clinics to deliver personalized, evidence-driven support where it matters most.
2023
Board Observer
May 2023
Alba Health is on a mission to improve the health of next generations. Join our movement to fight the chronic disease epidemic from childhood.
Show all 12 entries ↓
Investment activity
2020–2025 · 9 investments
202012021320221202312024120252
Recent (last 2 years)Earlier